Tag: CBT > IRS Code 280E Business

Cannabis Tax Law

Herbal Alternatives Dispensary Founder Pleads Guilty to $1.2 Million in Federal Tax Evasion

The former owner of the Washington, D.C.-based cannabis retailer admitted to not paying federal income and employment taxes for five tax years.

May 14, 2025

Federal Cannabis Legalization

US House Reps File Bill to Legalize Cannabis, Deliver 280E Relief, Permit Interstate Commerce

Three bipartisan U.S. lawmakers reintroduced the STATES Act to federally deschedule cannabis and end 85-plus years of prohibition.

April 21, 2025

Cannabis Rescheduling

DEA Judge’s Orders, Trump’s DEA Pick, Doctors’ Rescheduling Appeal Lead CBT’s Top Stories in February

The administrative law judge’s orders regarding a trio of pro-rescheduling participants led Cannabis Business Times’ most-read articles this month.

February 26, 2025

Cannabis Rescheduling

7 US House Republicans File Bill to Prevent 280E Tax Relief for Cannabis Businesses

The legislation, sponsored by Texas Rep. Jodey Arrington, is similar to a bill recently offered by Sens. James Lankford, R-Okla., and Pete Ricketts, R-Neb.

February 24, 2025

Cannabis Rescheduling

2 US Senators Work With Prohibitionists to Stop 280E Relief Under Cannabis Rescheduling

Sens. James Lankford and Pete Ricketts worked with Smart Approaches to Marijuana on legislation to block potential tax relief under Schedule III.

February 10, 2025

Cannabis Business Profit Trends

Only 27% of US Cannabis Operators Profitable in 2024, Whitney Economics Reports

The industry data and economic research consultancy released its preliminary cannabis business conditions survey results.

August 14, 2024

Finance

Cresco Labs Determines IRS Section 280E Not Applicable to its Business

The company reported an improvement of more than 800 basis points year-over-year in its adjusted EBITDA margin for the second quarter of 2024.

August 8, 2024

Finance

Green Thumb CEO Urges DEA to ‘Do Their Job’ for Cannabis Rescheduling

Ben Kovler’s remarks came with the company’s second quarter financial results, which featured $280 million in revenue, an 11% year-over-year increase.

August 5, 2024

Cannabis Rescheduling

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

July 29, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Massachusetts

Will a Lawsuit Challenging CSA’s Constitutionality Move Forward?

Oral arguments were heard to determine the merits of a lawsuit challenging the federal government’s authority to enforce the Controlled Substances Act against state-legal, intrastate cannabis businesses.

May 22, 2024

Cannabis Tax Law

Does Trulieve’s Tax Strategy Tie Into a Bigger Cannabis Industry Battle?

How a possibly outdated legal precedent, a pending lawsuit against the U.S. Attorney General, the U.S. Constitution, the Clean Water Act and interstate waterways may all relate to Trulieve’s and other high-profile 280E tax refund cases—and what major legal ‘fight’ we’re going to see playing out this year.

May 22, 2024